You are here : Home > News > Breast cancer: new develoments for early cases

Scientific result | Cancer

Breast cancer: new develoments for early cases

​Researchers at the CEA-Joliot (I2BC) have used NMR to decipher a novel mechanism in breast cancers linked to the BRCA2 gene.

Published on 17 June 2020

BRCA2 is one of the susceptibility genes for breast and ovarian cancers. To date, this susceptibility has been attributed primarily to the function in DNA repair of the protein encoded by the BRCA2 gene. But what if another BRCA2 function was responsible, or co-responsible, for this pathophysiological mechanism?

In partnership with the Institut Curie, researchers from the CEA-Joliot (I2BC) have shown that three mutations found in patients are responsible for abnormalities during cell division and have dissected these mechanisms.

Frédéric Joliot Institute for Life Sciences - CEA
​Curie Institute

Top page